Myocardial viability twenty-four hours after orthotopic heart transplantation from non-heart-beating donors

Journal of Thoracic and Cardiovascular Surgery

Volumn 125, Issue 6, 2003, Pages 1217-1227

  Martin, Juergen ^a,b   Lutter, Georg ^a   Ihling, Christian ^a   Siepe, Matthias ^a   Wagner, Susanne ^a   Hilberath, Jan ^a   Kemper, Michael ^a   Sarai, Koppany ^a   Beyersdorf, Friedhelm ^a   Sellke, Frank W ^c   Spotnitz, Henry M ^c   Buckberg, Gerald D ^c   Levitsky, Sidney ^c   Grundeman, Paul ^c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; HTK SOLUTION; SODIUM PROTON EXCHANGE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CADAVER DONOR; CARDIOPLEGIA; CELL DAMAGE; CONTROLLED STUDY; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE REPERFUSION; HEART PRELOAD; HEART STROKE VOLUME; HEART TRANSPLANTATION; HISTOLOGY; NONHUMAN; PRIORITY JOURNAL; TISSUE PRESERVATION;

EID: 0037635208     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(02)73234-0     Document Type: Article

References (34)

1. Hosenpud JD, Bennett LE, Keck BM, Boucek MM, Novick RJ. The registry of the International Society for Heart and Lung Transplantation: Seventeenth official report-2000. J Heart Lung Transplant. 2000; 19:909-31.
2. +-exchange inhibitor HOE 642. Eur J Cardiothorac Surg. 1998;14:607-14.
3. Martin J, Sarai K, Yoshitake M, et al. Successful orthotopic pig heart transplantation from non-heart-beating donors. J Heart Lung Transplant. 1999;18:597-606.
4. Vinten-Johansen J, Thourani VH, Ronson RS, et al. Broad-spectrum cardioprotection with adenosine. Ann Thorac Surg. 1999:68:1942-8.
5. Fluorescent Microsphere Resource Center information Web site. Manual for using fluorescent microspheres to measure regional organ perfusion. University of Washington, Division of Pulmonary and Critical Care Medicine, Seattle. Available at: http://fmrc.pulmcc. washington.edu/fmrc/fmrc.html. Accessed December 12, 1999.
6. van Oosterhout MFM, Willigers HMM, Reneman RS, Prinzen FW. Fluorescent microspheres to measure organ perfusion: validation of a simplified sample processing technique. Am J Physiol Heart Circ Physiol. 1995;269:H725-33.
7. Swindle M. Porcine models in surgical research: an overview. In: Tumbleson ME, editor. Swine in biomedical research. New York: Plenum Press; 1986. p. 135-42.
8. Kass DA, Maughan WL. From "Emax" to pressure-volume relations: a broader view. Circulation. 1988;77:1203-12.
9. Yanagi S, Takeuchi K, Takeda T, Ishikawa M, Miura I. Comparison of the effects of dobutamine and isoproterenol in ischemic hearts by phosphorous-31 nuclear magnetic resonance spectroscopy. Jpn Circ J. 1994;S8:338-50.
10. Deussen A, Flesche CW, Lauer T, Sonntag M, Schrader J. Spatial heterogeneity of blood flow in the dog heart. II. Temporal stability in response to adrenergic stimulation. Pflugers Arch. 1996;432:451-61.
11. Parker PE, Bashour FA, Downey HF, Kechejian SJ, Williams AG. Coronary hemodynamics during reperfusion following acute coronary ligation in dogs. Am Heart J. 1975;90:593-9.
12. Heyndrickx GR, Baig H, Nellens P, Leusen I, Fishbein MC, Vatner SF. Depression of regional blood flow and wall thickening after brief coronary occlusion. Am J Physiol. 1978;234:H653-9.
13. Buckberg GD. Myocardial protection: an overview. Semin Thorac Cardiovasc Surg. 1993;5:98-106.
14. Pearl JM, Drinkwater DC, Laks H, Capouya ER, Gates RN. Leukocyte-depleted reperfusion of transplanted human hearts: a randomized, double-blind clinical trial. J Heart Lung Transplant. 1992;11:1082-92.
15. Byrne JG, Appleyard RF, Lee CC, et al. Controlled reperfusion of the regionally ischemic myocardium with leukocyte-depleted blood reduces stunning, the no-reflow phenomenon, and infarct size. J Thorac Cardiovasc Surg. 1992;103:66-72.
16. Roth M, Kraus B, Scheffold T, Reuthebuch O, Klövekorn WP, Bauer EP. The effect of leukocyte-depleted blood cardioplegia in patients with severe ventricular dysfunction: a randomized, double-blind study. J Thorac Cardiovasc Surg. 2000;120:642-50.
17. Pearl JM, Laks H, Drikwater DC, et al. Loss of endothelium-dependent vasodilatation and nitric oxide release after myocardial protection with University of Wisconsin solution. J Thorac Cardiovasc Surg. 1994;107:257-64.
18. Buckberg GD. Endothelial and myocardial stunning. J Thorac Cardiovasc Surg. 2000;120:640-1.
19. Olafsson B, Forman MB, Puett DW, et al. Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium end the no-reflow phenomenon. Circulation. 1987;76:1135-45.
20. Berne RM. The role of adenosine in the regulation of coronary blood flow. Circ Res. 1980;47:807-13.
21. Auchampach JA, Maruyama M, Carero I, Gross GJ. Pharmacological evidence for a role of ATP-dependent potassium channels in myocardial stunning. Circulation. 1992;86:311-9.
22. Hudspeth DA, Nakanishi K, Vinten-Johansen J, et al. Adenosine in blood cardioplegia prevents postischemic dysfunction in ischemically injure hearts. Ann Thorac Surg. 1994;58:1637-44.
23. Nataf P, Pavie A, Bracamontes L, Bors V, Cabrol C, Gandjbakhch I. Myocardial protection by blood cardioplegia and warm reperfusion in heart transplantation. Ann Thorac Surg. 1992;53:526-7.
24. Soots G, Crepin F, Prat A. Cold blood cardioplegia and warm cardioplegic reperfusion in heart transplantation. Eur J Cardiothorac Surg. 1991;5:400-5.
25. Pradas G, Cuenca J, Juffe A. Continuous warm reperfusion during heart transplantation. J Thorac Cardiovasc Surg. 1996;11:784-90.
26. Fung JJ. Use of non-heart-beating donors. Transplant Proc. 2000;32: 1510-1.
27. Light JA, Sasaki TM, Ayuino AQ, Barhyte DY, Gage F. Excellent long-term graft survival with kidneys from the uncontrolled non-heart-beating donor. Transplant Proc. 2000;32:186-7.
28. Gerstenkorn C, Oliveira D, MacPhee I, Chang R. Non-heart-beating donors for renal transplantation. Lancet. 2000;356:1854.
29. Reich DJ, Munoz SJ, Rothstein KD, et al. Controlled non-heart-beating donor liver transplantation: a successful single center experience, with topic update. Transplantation. 2000;70:1159-66.
30. Clayton HA, Swift SM, Turner JM, James RF, Bell PR. Non-heart-beating organ donors: a potential source of islets for transplantation? Transplantation. 2000;69:2094-8.
31. Wierup P, Andersen C, Janciauskas D, Bolys R, Sjoberg T, Steen S. Bronchial healing, lung parenchymal histology, and blood gases one month after transplantation of lungs topically cooled for 2 hours in the non-heart-beating cadaver. J Heart Lung Transplant. 2000;19:270-6.
32. Barnard CN. A human cardiac transplant: an interim reperot of a successful operation performed at Groote Schuur Hospital, Cape Town. S Afr Med J. 1967;41:1271-5.
33. Dureau G. Heart transplant from non-beating heart donor. Past experience and report of one clinical case. In: Touraine JL, Traeger J, Betuel H, Dubernard JM, Revillard JP, Dupuy C, editors. Organ shortage: the solutions. Dordrecht: Kluwer Academic Publishers; 1995. p. 61-6.
34. Cooper DKC. The donor heart. The present position with regard to resuscitation, storage, and assessment of viability. J Surg Res. 1976; 21:363-81.